Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Esposito Pamela
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-04
Sale
2021-08-06
9:01 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
30,000 $35.08 $1,052,322 327,459
(Direct)
View
2021-07-20
Sale
2021-07-22
9:01 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
17,400 $33.14 $576,575 325,103
(Direct)
View
2021-07-15
Sale
2021-07-19
9:02 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
4,600 $33.37 $153,502 278,762
(Direct)
View
2021-01-14
Sale(A)
2021-07-19
9:02 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $43.99 $2,419,344 436,330
(Direct)
View
2021-01-14
Sale
2021-01-19
9:50 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $43.99 $2,419,344 436,330
(Direct)
View
2020-10-14
Sale
2020-10-16
6:05 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $32.9 $526,410 240,903
(Direct)
View
2020-08-31
Sale
2020-09-01
5:13 pm
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $27.05 $135,250 256,903
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-08-04
Exercise
2021-08-06
9:01 pm
N/A
2029-04-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
30,000 $0 327,459
(Direct)
View
2021-08-04
Exercise
2021-08-06
9:01 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
30,000 $15.5 327,459
(Direct)
View
2021-07-20
Exercise
2021-07-22
9:01 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
17,400 $0 325,103
(Direct)
View
2021-07-20
Exercise
2021-07-22
9:01 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
17,400 $1.01 325,103
(Direct)
View
2021-07-15
Exercise
2021-07-19
9:02 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
4,600 $0 278,762
(Direct)
View
2021-07-15
Exercise
2021-07-19
9:02 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
4,600 $1.01 278,762
(Direct)
View
2021-01-14(A)
Exercise
2021-07-19
9:02 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $0 436,330
(Direct)
View
2021-01-14(A)
Exercise
2021-07-19
9:02 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $1.01 436,330
(Direct)
View
2021-06-16
Option Award
2021-06-17
4:50 pm
N/A
2031-06-15
Kymera Therapeutics Inc. KYMR Esposito Pamela
Director
20,063 $0 20,063
(Direct)
View
2021-04-01
Option Award
2021-04-05
8:20 pm
N/A
2031-04-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
85,415 $0 261,409
(Direct)
View
2021-01-14
Exercise
2021-01-19
9:50 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $0 436,330
(Direct)
View
2021-01-14
Exercise
2021-01-19
9:50 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
55,000 $1.01 436,330
(Direct)
View
2020-12-23
Exercise
2020-12-28
9:01 pm
N/A
2026-03-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
50,704 $0 208,752
(Direct)
View
2020-12-23
Exercise
2020-12-28
9:01 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
50,704 $1.75 208,752
(Direct)
View
2020-12-11
Exercise
2020-12-15
9:35 pm
N/A
2027-07-26
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
12,590 $0 246,981
(Direct)
View
2020-12-11
Exercise
2020-12-15
9:35 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
12,590 $3.3 246,981
(Direct)
View
2020-10-14
Exercise
2020-10-16
6:05 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $0 240,903
(Direct)
View
2020-10-14
Exercise
2020-10-16
6:05 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
16,000 $1.01 240,903
(Direct)
View
2020-09-04
Option Award
2020-09-09
4:51 pm
N/A
2030-09-03
Kymera Therapeutics Inc. KYMR Esposito Pamela
Director
40,127 $0 40,127
(Direct)
View
2020-08-31
Exercise
2020-09-01
5:13 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $0 256,903
(Direct)
View
2020-08-31
Exercise
2020-09-01
5:13 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
5,000 $1.01 256,903
(Direct)
View
2020-04-01
Option Award
2020-04-02
4:35 pm
N/A
2030-04-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
85,450 $0 85,450
(Direct)
View
2019-12-20
Exercise
2019-12-23
4:32 pm
N/A
2026-03-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
25,700 $0 196,162
(Direct)
View
2019-12-20
Exercise
2019-12-23
4:32 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
25,700 $1.75 196,162
(Direct)
View
2019-04-01
Option Award
2019-04-03
5:21 pm
N/A
2029-04-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
75,750 $0 75,750
(Direct)
View
2018-12-13
Exercise
2018-12-17
4:16 pm
N/A
2026-03-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
87,000 $0 196,162
(Direct)
View
2018-12-13
Exercise
2018-12-17
4:16 pm
N/A
N/A
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
87,000 $1.75 196,162
(Direct)
View
2018-07-24
Option Award
2018-07-26
5:23 pm
N/A
2028-07-19
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
70,000 $0 70,000
(Direct)
View
2018-07-19
Ownership
2018-07-19
8:47 pm
N/A
2025-11-01
Replimune Group Inc. REPL Esposito Pamela
Chief Business Officer
0 $0 479,646
(Direct)
View
(A) Indicate amendment filing.